Clinical decision-making for vitamin K-1 and K-2 deficiency and coronary artery calcification with warfarin therapy: Are diet, factor Xa inhibitors or both the answer?

Asia Pacific Journal of Clinical Nutrition

Volumn 22, Issue 3, 2013, Pages 492-496

  Wahlqvist, Mark L ^a,b   Tanaka, Kiyoshi ^c   Tzeng, Bing Hsiean ^d,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b MONASH UNIVERSITY   (Australia)

^c KYOTO WOMEN'S UNIVERSITY   (Japan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Apixaban; Cheese and natto; Coronary artery calcification; Vitamin K deficiency syndromes; Warfarin therapy

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FARNOQUINONE; PHYTOMENADIONE; WARFARIN;

ARTICLE; CALCINOSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; DIET; DIET THERAPY; DRUG ANTAGONISM; HUMAN; MALE; MIDDLE AGED; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; VITAMIN K DEFICIENCY;

CALCINOSIS; CORONARY ARTERY DISEASE; DIET; FACTOR XA; HUMANS; MALE; MIDDLE AGED; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; VITAMIN K 1; VITAMIN K 2; VITAMIN K DEFICIENCY; WARFARIN;

EID: 84883777898     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.2013.22.3.21     Document Type: Article

References (21)

1. Berkner KL. Vitamin K-dependent carboxylation. Vitam Horm. 2008:131-56. doi: 10.1016/s0083-6729(07)00007-6.
2. Guylaine F. Vitamin K. In: Erdman JR, McDonald IA, Zeisel SH, editors. Present Knowledge in Nutrition. Oxford: Wiley Blackwell; 2012. pp. 230-47.
3. Schurgers LJ, Aebert H, Vermeer C, Bultmann B, Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood. 2004;10:3231-2. doi: 10.1182/blood-2004-04-1277.
4. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002;1:27-32.
5. Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol. 2008;5:1504-10. doi: 10.2215/cjn.00770208.
6. Thijssen HH, Drittij-Reijnders MJ. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br J Nutr. 1996:121-27.
7. Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarintreated rats. J Vasc Res. 2003;6:531-7. doi: 75344.
8. Booth SL. Roles for vitamin K beyond coagulation. Annu Rev Nutr. 2009:89-110. doi: 10.1146/annurev-nutr-080508-141217.
9. Kuwabara A, Fujii M, Kawai N, Tozawa K, Kido S, Tanaka K. Bone is more susceptible to vitamin K deficiency than liver in the institutionalized elderly. Asia Pac J Clin Nutr. 2011;1:50-5.
10. Nakano T, Tsugawa N, Kuwabara A, Kamao M, Tanaka K, Okano T. High prevalence of hypovitaminosis D and K in patients with hip fracture. Asia Pac J Clin Nutr. 2011;1:56-61
11. Nagae A, Kuwabara A, Tozawa K, Kumode M, Takeuchi Y, Tanaka K. Enteral nutrition and antibiotic use increase the risk for vitamin K deficiency in patients with severe motor and intellectual disabilities. ESPEN J. 2013;1-6. doi: 10. 1016/j.clnme.2012.12.002
12. Zhu D, Mackenzie NC, Farquharson C, Macrae VE. Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne). 2012:95. doi: 10. 3389/fendo.2012.00095.
13. Kuwabara A, Himeno M, Tsugawa N, Kamao M, Fujii M, Kawai N et al. Hypovitaminosis D and K are highly prevalent and independent of overall malnutrition in the institutionalized elderly. Asia Pac J Clin Nutr. 2010;1:49-56.
14. Alfadda A, Masood A, Shaik S, Dekhil H, Goran M. Association between osteocalcin, metabolic syndrome, and cardiovascular risk factors: role of total and undercarboxylated osteocalcin in patients with type 2 diabetes. Int J Endocrinol. 2013;2013:197519. doi: 10.1155/2013/197519.
15. Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res. 2011;4:677-80. doi: 10.1002/jbmr.321.
16. Kaiser C, Agus ZS. Coronary calcium linked to maintenance warfarin. [cited 2013/7/26]; Available from: http://www.medpagetoday.com/Cardiology/Arrhythmias/27768.
17. Lee CD, Jacobs DR, Jr., Schreiner PJ, Iribarren C, Hankinson A. Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2007;1:48-54.
18. Danilevicius CF, Lopes JB, Pereira RMR. Bone metabolism and vascular calcification. Braz J Med Biol Res. 2007;40: 435-42. doi: 10.1590/S0100-879X2007000400001.
19. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;11:3100-5.
20. Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, Witteman JC, Grobbee DE, van der Schouw YT. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;2:489-93. doi: 10.1016/j.atherosclerosis.2008.07.010.
21. Adams J, Pepping J. Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health Syst Pharm. 2005;15:1574-81. doi: 10.2146/ajhp040 357.